According to The Lancet [2], it produced meaningful glycaemic improvements and notable weight reductions in type 2 diabetes research
Drop one dose level every 4 weeks (for example, from 10mg to 7.5mg to 5mg to 2.5mg)
It is a small molecule, not a true peptide, even though it is often sold alongside research peptides
Clinical studies of tesamorelin and other metabolic peptides typically evaluate changes over 36 months, with visceral fat reductions and lab improvements often emerging gradually over that timeframe
Journal of Medicinal Chemistry (ACS) Bisubstrate inhibitors of NNMT with enhanced activity PMC NNMT: a bad actor in fat makes good in liver Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides